Hydrogen exerts neuroprotective effects by inhibiting oxidative stress in experimental diabetic peripheral neuropathy rats.
Xiao-Chen Han, Zhou-Heng Ye, Hui-Jun Hu, Qiang Sun, Dan-Feng Fan · Medical gas research · 2023
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, mNCV of diabetic rats receiving hydrogen administration was significantly improved compared with that in the DM group ( P < 0.05) ( Figure 3 ). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how subcutaneous hydrogen gas injection affected the outcomes measured in rats. MNCV of diabetic rats receiving hydrogen administration was significantly improved compared with that in the DM group ( P < 0.05) ( Figure 3 ).
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
MNCV of diabetic rats receiving hydrogen administration was significantly improved compared with that in the DM group ( P < 0.05) ( Figure 3 ). The authors concluded that the authors' paper showed that hydrogen exerts significant protective effects in DPN by downregulating oxidative stress via the pathway of nuclear factor erythroid-2-related factor 2, which suggests its potential value in clinical applications. Hydrogen significantly attenuated oxidative stress by reducing the level of malondialdehyde, reactive oxygen species, and 8-hydroxy-2-deoxyguanosine and meaningfully enhanced the antioxidant capability by partially restoring the activities of superoxide dismutase.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The reported sample size was 42. The study used a preclinical animal experiment. The hydrogen delivery method was subcutaneous hydrogen gas injection.
Limitations and Safety
Reported limitations: Here are the limitations of this study.Firstly, there is a lack of experiments on the exact molecular mechanism of hydrogen in DPN.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.